NRG-GY020: A PHASE III RANDOMIZED TRIAL OF RADIATION +/- PEMBROLIZUMAB (MK-3475) FOR NEWLY DIAGNOSED EARLY STAGE HIGH INTERMEDIATE RISK MISMATCH REPAIR DEFICIENT (dMMR) ENDOMETRIOID ENDOMETRIAL CANCER

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

Highlands Ranch Hospital
Memorial Hospital Central
Memorial Hospital North
University of Colorado Hospital

Study ID

Protocol Number: 21-3887

More information available at ClinicalTrials.gov: NCT04214067

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers